Andrew is a founder and Managing Director of AdvanCell Isotopes, and a founder and Director of Riverland Capital, a private investment firm.
Julian has over 20 years expertise working with & managing nuclear & radioactive materials and a Ph.D in chemical physics (ANU).
Simon completed a PhD in Chemistry at the University of Nottingham in 2012, focused on the use of nuclear magnetic resonance spectroscopy to understand the spatial organisation of ionic liquids.
Dr Peter Whitfeld has over 30 years’ experience in biotechnology research & development and in intellectual property and contracts management.
.webp)
.webp)
.webp)
.webp)
.svg){kind=icon}
